Stocks Hitting 52-Week Lows

shares fell 13.99 percent to reach a new 52-week low of $28.04 after the company reported weaker-than-expected Q1 earnings.

shares touched a new 52-week low of $11.04 following announcement of failed pancreatic cancer trial.

shares fell 11.46 percent to touch a new 52-week low of $19.31. Gap reported a 7 percent drop in its same-store sales for April. The company's total sales declined to $1.12 billion, from $1.21 billion in the year-ago month. Gap also issued a weak forecast for the first quarter.

shares dropped 5.45 percent to touch a new 52-week low of $5.38 following Q1 results. Net sales at the combined networks business slipped 8 percent to 5.18 billion euros.